Multidrug resistance in Gram-negative bacteria that produce extended-spectrum β-lactamases (ESBLs)
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11, 1-16
- https://doi.org/10.1111/j.1469-0691.2005.01160.x
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Routine Cycling of Antimicrobial Agents as an Infection-Control MeasureClinical Infectious Diseases, 2003
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- TEM-72, a New Extended-Spectrum β-Lactamase Detected in Proteus mirabilis and Morganella morganii in ItalyAntimicrobial Agents and Chemotherapy, 2000
- β-Lactamases in Shigella flexneri Isolates from Hong Kong and Shanghai and a Novel OXA-1-Like β-Lactamase, OXA-30Antimicrobial Agents and Chemotherapy, 2000
- Biochemical-Genetic Characterization and Distribution of OXA-22, a Chromosomal and Inducible Class D β-Lactamase fromRalstonia(Pseudomonas)pickettiiAntimicrobial Agents and Chemotherapy, 2000
- Capnocytophaga ochracea : Characterization of a Plasmid-Encoded Extended-Spectrum TEM-17 β-Lactamase in the Phylum Flavobacter-BacteroidesAntimicrobial Agents and Chemotherapy, 2000
- Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inoculaThe Pediatric Infectious Disease Journal, 1997
- Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamasesFEMS Microbiology Letters, 1997
- Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactamThe Lancet, 1994
- Animal models of pneumonia for evaluation of antimicrobial therapyJournal of Antimicrobial Chemotherapy, 1985